Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 9 studies | 28% ± 11% | |
retinal bipolar neuron | 5 studies | 41% ± 14% | |
interneuron | 5 studies | 34% ± 20% | |
GABAergic neuron | 4 studies | 31% ± 15% | |
glutamatergic neuron | 4 studies | 43% ± 8% | |
OFF-bipolar cell | 3 studies | 33% ± 9% | |
ON-bipolar cell | 3 studies | 21% ± 4% | |
rod bipolar cell | 3 studies | 83% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 79% | 386.61 | 2090 / 2642 | 60% | 4.81 | 425 / 705 |
pancreas | 29% | 22.47 | 95 / 328 | 23% | 1.05 | 41 / 178 |
adrenal gland | 17% | 16.14 | 43 / 258 | 22% | 3.18 | 50 / 230 |
uterus | 27% | 49.14 | 46 / 170 | 2% | 0.06 | 7 / 459 |
adipose | 10% | 13.49 | 122 / 1204 | 0% | 0 | 0 / 0 |
bladder | 10% | 6.62 | 2 / 21 | 1% | 0.16 | 3 / 504 |
kidney | 1% | 0.60 | 1 / 89 | 7% | 0.30 | 66 / 901 |
blood vessel | 7% | 6.51 | 99 / 1335 | 0% | 0 | 0 / 0 |
intestine | 3% | 2.17 | 33 / 966 | 2% | 0.06 | 8 / 527 |
prostate | 5% | 7.57 | 12 / 245 | 0% | 0 | 0 / 502 |
eye | 0% | 0 | 0 / 0 | 3% | 0.10 | 2 / 80 |
stomach | 2% | 1.16 | 6 / 359 | 1% | 0.02 | 2 / 286 |
breast | 1% | 0.83 | 5 / 459 | 1% | 0.07 | 10 / 1118 |
skin | 1% | 1.45 | 20 / 1809 | 0% | 0.03 | 2 / 472 |
esophagus | 0% | 0.18 | 4 / 1445 | 1% | 0.01 | 2 / 183 |
lung | 0% | 0.09 | 1 / 578 | 1% | 0.05 | 13 / 1155 |
thymus | 0% | 0.18 | 2 / 653 | 0% | 0 | 0 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
Gene name | TMEM196 |
Protein name | Transmembrane protein 196 |
Synonyms | |
Description | FUNCTION: Acts as a tumor suppressor in lung cancer . Inhibits tumor cell growth by inhibiting cell proliferation and migration and promoting cell apoptosis . Inhibits metastasis of lung cancer by suppressing beta-catenin expression in the Wnt/beta-catenin signaling pathway (By similarity). . |
Accessions | F8WE15 ENST00000422233.5 ENST00000405764.7 [Q5HYL7-4] ENST00000493519.2 [Q5HYL7-2] B7WNR7 Q5HYL7 ENST00000405844.6 |